# Intertwining of the IGF system and animal welfare

**Authors:** Anne-Marie Galow, Daniela Ohde, Anja Eggert, Christina Walz, Marianne Zenk, Chaithra Umesh, Saptarshi Bej, Olaf Wolkenhauer, Andreas Hoeflich

PMC · DOI: 10.1038/s41598-026-42315-3 · Scientific Reports · 2026-03-04

## TL;DR

This study explores how different housing conditions affect the IGF system in sows, suggesting it could help objectively assess animal welfare.

## Contribution

The study introduces a novel bioassay to evaluate IGF system activity as a potential indicator of animal welfare.

## Key findings

- Differential housing conditions altered serum IGF bioactivities in sows.
- IGF system factors varied depending on housing conditions during pregnancy and lactation.
- Principal component analysis suggests IGF factors may distinguish sows by housing environment.

## Abstract

To date, husbandry categories are defined based on the human concept of animal needs, however, to objectively assess animal welfare in defined husbandry systems, animal-related indicators must be evaluated. Here, we studied the impact of differential housing conditions on factors of the insulin-like growth factor system (IGF-system) in mother sows either housed in a conventional husbandry system corresponding to the regulations of the German husbandry form 1, or in the associated ecological facility, corresponding to the German husbandry form 4/5. Utilizing a proprietary bioassay that determines the activity of the IGF system at the level of intracellular signal transduction, we revealed altered serum IGF bioactivities in differentially housed sows. Moreover, we present a comprehensive analysis of the individual factors of the IGF system in serum of pregnant and lactating sows to elucidate which of these are modified depending on the housing conditions. An unsupervised principal component analysis suggests that IGF system factors might distinguish sows based on their housing environment. These results imply that the IGF system provides a solid basis for the documentation and objective assessment of animal health and welfare. However, a robust biomarker system for animal welfare assessment will likely require a multifactorial and integrative approach.

The online version contains supplementary material available at 10.1038/s41598-026-42315-3.

## Full-text entities

- **Genes:** IGFBP3 (insulin like growth factor binding protein 3) [NCBI Gene 448812] {aka IGFBP-3}, Igfbp2 (insulin-like growth factor binding protein 2) [NCBI Gene 16008] {aka IBP-2, Igfbp-2, mIGFBP-2}, PAPPA2 (pappalysin 2) [NCBI Gene 100521390], PRL (prolactin) [NCBI Gene 396965], STC1 (stanniocalcin 1) [NCBI Gene 100125345], IGF2 (insulin like growth factor 2) [NCBI Gene 396916] {aka IGF-II}, IGFBP2 (insulin like growth factor binding protein 2) [NCBI Gene 3485] {aka IBP2, IGF-BP53}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, STC2 (stanniocalcin 2) [NCBI Gene 100126236], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 100127359] {aka FRAP1}, BDNF (brain derived neurotrophic factor) [NCBI Gene 397495], PAPPA (pappalysin 1) [NCBI Gene 397219] {aka PAPP-A}, IGF2 (insulin like growth factor 2) [NCBI Gene 3481] {aka C11orf43, GRDF, IGF-II, PP9974, SRS3}, IGFBP2 (insulin like growth factor binding protein 2) [NCBI Gene 397064] {aka pIGFBP-2}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 397350], Igf2 (insulin-like growth factor 2) [NCBI Gene 24483] {aka IGFII, RNIGF2}, HCRT (hypocretin neuropeptide precursor) [NCBI Gene 397305], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 100126861] {aka Akt, PKB}, Igf1 (insulin-like growth factor 1) [NCBI Gene 24482] {aka IGF}, IGF1 (Insulin-like growth factor 1 level) [NCBI Gene 101055342], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, IGFBP4 (insulin like growth factor binding protein 4) [NCBI Gene 100144490] {aka IBP-4, IBP4, IGFBP-4}, VIM (vimentin) [NCBI Gene 7431], IGF1 (insulin like growth factor 1) [NCBI Gene 3479] {aka IGF, IGF-I, IGFI, MGF}, DSPP (dentin sialophosphoprotein) [NCBI Gene 396664] {aka DPP, DSP}
- **Diseases:** underweight (MESH:D013851), REML (MESH:D002313), tumorigenic (MESH:D002471), agitation (MESH:D011595), injuries (MESH:D014947), behavioral disorders (MESH:D001523), anxiety (MESH:D001007)
- **Chemicals:** CO2 (MESH:D002245), BCA (MESH:C047117), BMS (MESH:C095300), FBS (MESH:C523711), Cloprostenol (MESH:D003008), KCl (MESH:D011189), Tween 20 (MESH:D011136), PBS (MESH:D007854), PVDF (MESH:C024865), serotonin (MESH:D012701), neomycin (MESH:D009355), Calcium (MESH:D002118), Oxytocin (MESH:D010121), Longacton (-), penicillin (MESH:D010406), glycerine (MESH:D005990), amphotericin B (MESH:D000666), Tris (MESH:D014325), Cl (MESH:D002713), water (MESH:D014867), iron (MESH:D007501), Carbetocin (MESH:C020731), biotin (MESH:D001710), GABA (MESH:D005680), SDS (MESH:D012967), Glutamate (MESH:D018698), PGF (MESH:D011460), acrylamide (MESH:D020106), Prostaglandin F2alpha (MESH:D015237), NaCl (MESH:D012965), Cortisol (MESH:D006854), EDTA (MESH:D004492), prostaglandin (MESH:D011453), bromophenol blue (MESH:D001978), streptomycin (MESH:D013307), CORT (MESH:D003348)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12963405/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12963405/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC12963405/full.md

---
Source: https://tomesphere.com/paper/PMC12963405